RTK class IV and X; EC 2.7.10.1
| Axon ID | Name | Description | From price | |
|---|---|---|---|---|
| 1959 | Golvatinib | Potent and orally available inhibitor of c-MET (HGFR) and VEGFR2 | €90.00 | |
| 1819 | Cabozantinib S-malate | Inhibitor of multiple receptor tyrosine kinases, specifically MET and VEGFR2 | €60.00 | |